Franklin Resources Inc. Has $139.37 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Franklin Resources Inc. increased its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 0.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,640,215 shares of the company's stock after purchasing an additional 11,659 shares during the period. Franklin Resources Inc. owned 1.88% of HealthEquity worth $139,369,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in HQY. SG Americas Securities LLC boosted its stake in HealthEquity by 48.5% during the 2nd quarter. SG Americas Securities LLC now owns 3,798 shares of the company's stock valued at $327,000 after purchasing an additional 1,241 shares during the period. Wealth Enhancement Advisory Services LLC bought a new position in HealthEquity in the 2nd quarter worth approximately $265,000. Raymond James & Associates increased its position in HealthEquity by 11.3% in the 2nd quarter. Raymond James & Associates now owns 149,407 shares of the company's stock valued at $12,879,000 after acquiring an additional 15,140 shares during the period. Nisa Investment Advisors LLC increased its position in HealthEquity by 7.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company's stock valued at $246,000 after acquiring an additional 198 shares during the period. Finally, Fifth Third Wealth Advisors LLC bought a new stake in HealthEquity during the 2nd quarter valued at $238,000. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Activity at HealthEquity

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the company's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the sale, the director now owns 3,784 shares of the company's stock, valued at $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now owns 54,719 shares in the company, valued at approximately $4,540,582.62. This trade represents a 13.10 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 43,786 shares of company stock valued at $4,140,387. 2.20% of the stock is currently owned by corporate insiders.

HealthEquity Stock Down 2.6 %

Shares of NASDAQ:HQY traded down $2.45 during trading on Monday, reaching $93.17. 796,788 shares of the company traded hands, compared to its average volume of 636,079. The company has a quick ratio of 4.10, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 1-year low of $62.50 and a 1-year high of $105.82. The firm has a fifty day simple moving average of $94.28 and a 200 day simple moving average of $84.36. The firm has a market cap of $8.07 billion, a P/E ratio of 85.48, a price-to-earnings-growth ratio of 1.10 and a beta of 0.55.

Analyst Ratings Changes

A number of analysts have commented on HQY shares. Barrington Research boosted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a research report on Monday, December 2nd. The Goldman Sachs Group started coverage on HealthEquity in a report on Friday, November 15th. They set a "neutral" rating and a $108.00 target price on the stock. Royal Bank of Canada increased their price target on HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a research note on Tuesday, December 10th. Mizuho started coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price objective on the stock. Finally, BTIG Research raised their target price on HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $110.71.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.